| Source: |
| Type: |
| Tumor cell proliferation is a key characteristic of cancer. It refers to the rapid and uncontrolled growth of cells that can lead to the formation of tumors. |
| 5176- | BBR, | Berberine regulates AMP-activated protein kinase signaling pathways and inhibits colon tumorigenesis in mice |
| - | vitro+vivo, | CRC, | HCT116 | - | in-vitro, | CRC, | SW480 | - | in-vitro, | CRC, | LoVo |
| 5634- | BCA, | Molecular Mechanisms of Biochanin A in AML Cells: Apoptosis Induction and Pathway-Specific Regulation in U937 and THP-1 |
| - | in-vitro, | AML, | U937 | - | in-vitro, | AML, | THP1 |
| 5639- | BCA, | Biochanin A Induces Apoptosis in MCF-7 Breast Cancer Cells through Mitochondrial Pathway and Pi3K/AKT Inhibition |
| - | in-vitro, | BC, | NA |
| 6518- | BCP, | beta-Caryophyllene Induces Apoptosis and Inhibits Angiogenesis in Colorectal Cancer Models |
| - | vitro+vivo, | CRC, | HCT116 |
| 6514- | BCP, | Effects of β-caryophyllene and oxygen availability on cholesterol and fatty acids in breast cancer cells |
| - | in-vitro, | BC, | NA |
| 6512- | BCP, | Beta-Caryophyllene Exhibits Anti-Proliferative Effects through Apoptosis Induction and Cell Cycle Modulation in Multiple Myeloma Cells |
| - | in-vitro, | MM, | NA |
| 6503- | BCP, | The Potential Therapeutic Role of Beta-Caryophyllene as a Chemosensitizer and an Inhibitor of Angiogenesis in Cancer |
| - | Review, | Var, | NA |
| 6499- | BCP, | JAK1/STAT3 regulatory effect of β-caryophyllene on MG-63 osteosarcoma cells via ROS-induced apoptotic mitochondrial pathway by DNA fragmentation |
| - | in-vitro, | OS, | MG63 |
| 6500- | BCP, | Beta-Caryophyllene Suppresses Ovarian Cancer Proliferation by Inducing Cell Cycle Arrest and Apoptosis |
| - | in-vitro, | Ovarian, | NA |
| 6497- | BCP, | Cisplatin, | Beta-Caryophyllene Enhances the Anti-Tumor Activity of Cisplatin in Lung Cancer Cell Lines through Regulating Cell Cycle and Apoptosis Signaling Molecules |
| - | in-vitro, | Lung, | NA |
| 6509- | BCP, | βcaryophyllene oxide induces apoptosis and inhibits proliferation of A549 lung cancer cells |
| - | in-vitro, | Lung, | A549 |
| 5510- | bemA, | Combined inhibition of ACLY and CDK4/6 reduces cancer cell growth and invasion |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | PC, | NA |
| 2730- | BetA, | Betulinic acid induces autophagy-dependent apoptosis via Bmi-1/ROS/AMPK-mTOR-ULK1 axis in human bladder cancer cells |
| - | in-vitro, | Bladder, | T24/HTB-9 |
| 2733- | BetA, | Betulinic Acid Inhibits Cell Proliferation in Human Oral Squamous Cell Carcinoma via Modulating ROS-Regulated p53 Signaling |
| - | in-vitro, | Oral, | KB | - | in-vivo, | NA, | NA |
| 2737- | BetA, | Multiple molecular targets in breast cancer therapy by betulinic acid |
| - | Review, | Var, | NA |
| 2740- | BetA, | Effects and mechanisms of fatty acid metabolism-mediated glycolysis regulated by betulinic acid-loaded nanoliposomes in colorectal cancer |
| - | in-vitro, | CRC, | HCT116 |
| 2756- | BetA, | Betulinic acid inhibits growth of hepatoma cells through activating the NCOA4-mediated ferritinophagy pathway |
| - | in-vitro, | HCC, | HUH7 | - | in-vitro, | HCC, | H1299 |
| 5515- | BEV, | Biological activity of bevacizumab, a humanized anti-VEGF antibody in vitro. |
| - | Review, | Var, | NA |
| 5725- | BF, | TMZ, | Bufalin Induces Apoptosis and Improves the Sensitivity of Human Glioma Stem-Like Cells to Temozolamide |
| - | in-vitro, | GBM, | NA |
| 5726- | BF, | Bufalin exerts antitumor effects in neuroblastoma via the induction of reactive oxygen species-mediated apoptosis by targeting the electron transport chain |
| - | Review, | neuroblastoma, | SK-N-BE |
| 5727- | BF, | Bufalin Inhibits Proliferation and Induces Apoptosis in Osteosarcoma Cells by Downregulating MicroRNA-221 |
| - | in-vitro, | OS, | U2OS |
| 5728- | BF, | Effects of bufalin on the proliferation of human lung cancer cells and its molecular mechanisms of action |
| - | in-vitro, | Lung, | A549 |
| 5730- | BF, | Bufalin Is a Potent Small-Molecule Inhibitor of the Steroid Receptor Coactivators SRC-3 and SRC-1 |
| - | in-vitro, | BC, | MCF-7 | - | in-vitro, | Lung, | A549 |
| 5719- | BF, | Bufalin inhibits the proliferation of lung cancer cells by suppressing Hippo-YAP pathway |
| - | in-vitro, | Lung, | NA |
| 5715- | BF, | Bufalin for an innovative therapeutic approach against cancer |
| - | Review, | Var, | NA |
| 5686- | BJ, | BRU, | A review of Brucea javanica: metabolites, pharmacology and clinical application |
| - | Review, | Var, | NA |
| 5689- | BJ, | Brucea javanica oil inhibited the proliferation, migration, and invasion of oral squamous carcinoma by regulated the MTFR2 pathway |
| - | vitro+vivo, | Oral, | CAL27 |
| 5481- | BM, | Therapeutic potential of Bacopa monnieri extracts against hepatocellular carcinoma through in-vitro and computational studies |
| - | in-vitro, | HCC, | HepG2 |
| 5486- | BM, | Bacopaside I, acting as an aquaporin 1 inhibitor, ameliorates rheumatoid arthritis via suppressing aquaporin 1-mediated autophagy |
| - | in-vivo, | Arthritis, | NA |
| 5677- | BML, | Bromelain inhibits nuclear factor kappa-B translocation, driving human epidermoid carcinoma A431 and melanoma A375 cells through G(2)/M arrest to apoptosis |
| - | in-vitro, | Melanoma, | A431 | - | in-vitro, | Melanoma, | A375 |
| 5653- | BNL, | Borneol hinders the proliferation and induces apoptosis through the suppression of reactive oxygen species-mediated JAK1 and STAT-3 signaling in human prostate cancer cells |
| - | in-vitro, | Pca, | PC3 |
| 3512- | Bor, | Activation of the EIF2α/ATF4 and ATF6 Pathways in DU-145 Cells by Boric Acid at the Concentration Reported in Men at the US Mean Boron Intake |
| - | in-vitro, | Pca, | DU145 |
| 3513- | Bor, | Boric Acid Activation of eIF2α and Nrf2 Is PERK Dependent: a Mechanism that Explains How Boron Prevents DNA Damage and Enhances Antioxidant Status |
| - | in-vitro, | Pca, | DU145 | - | in-vitro, | Nor, | MEF |
| 3786- | Bor, | New and potential boron-containing compounds for treatment of Alzheimer's disease and cancers |
| - | Analysis, | AD, | NA | - | Analysis, | Var, | NA |
| 4620- | Bor, | BTZ, | Boron Compounds in the Breast Cancer Cells Chemoprevention and Chemotherapy |
| - | Review, | Var, | NA | - | Review, | Arthritis, | NA | - | Review, | Pca, | NA |
| 705- | Bor, | Boric acid inhibits human prostate cancer cell proliferation |
| - | in-vitro, | Pca, | DU145 | - | in-vitro, | Pca, | LNCaP |
| 739- | Bor, | Borax regulates iron chaperone- and autophagy-mediated ferroptosis pathway in glioblastoma cells |
| - | in-vitro, | GBM, | U87MG | - | in-vitro, | Nor, | HMC3 |
| 763- | Bor, | Investigation of The Apoptotic and Antiproliferative Effects of Boron on CCL-233 Human Colon Cancer Cells |
| - | in-vitro, | Colon, | CCl233 |
| 768- | Bor, | In vitro and in vivo antitumour effects of phenylboronic acid against mouse mammary adenocarcinoma 4T1 and squamous carcinoma SCCVII cells |
| - | in-vitro, | BC, | 4T1 |
| 738- | Bor, | Borax induces ferroptosis of glioblastoma by targeting HSPA5/NRF2/GPx4/GSH pathways |
| - | in-vitro, | GBM, | U251 | - | in-vitro, | GBM, | A172 | - | in-vitro, | Nor, | SVGp12 |
| 710- | Bor, | Boric acid inhibits stored Ca2+ release in DU-145 prostate cancer cells |
| - | in-vitro, | Pca, | DU145 |
| 722- | Bor, | Boric acid as a promising agent in the treatment of ovarian cancer: Molecular mechanisms |
| - | in-vitro, | Ovarian, | MDAH-2774 |
| 2768- | Bos, | Boswellic acids as promising agents for the management of brain diseases |
| - | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
| 1248- | Bos, | The anti-proliferative effects of a frankincense extract in a window of opportunity phase ia clinical trial for patients with breast cancer |
| - | Trial, | BC, | NA |
| 1420- | Bos, | Acetyl-11-keto-β-boswellic acid inhibits proliferation and induces apoptosis of gastric cancer cells through the phosphatase and tensin homolog /Akt/ cyclooxygenase-2 signaling pathway |
| - | vitro+vivo, | GC, | BGC-823 |
| 1416- | Bos, | Anti-cancer properties of boswellic acids: mechanism of action as anti-cancerous agent |
| - | Review, | NA, | NA |
| 1448- | Bos, | A triterpenediol from Boswellia serrata induces apoptosis through both the intrinsic and extrinsic apoptotic pathways in human leukemia HL-60 cells |
| - | in-vitro, | AML, | HL-60 |
| 1449- | Bos, | Chemo, | Anti-proliferative, Pro-apoptotic, and Chemosensitizing Potential of 3-Acetyl-11-keto-β-boswellic Acid (AKBA) Against Prostate Cancer Cells |
| - | in-vitro, | Pca, | PC3 |
| 5695- | BRU, | Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism |
| - | in-vitro, | Lung, | A549 |
| 5691- | BRU, | Brusatol Inhibits Proliferation, Migration, and Invasion of Nonsmall Cell Lung Cancer PC-9 Cells |
| - | in-vitro, | Lung, | PC9 | - | in-vitro, | Lung, | H1975 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:327 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid